Property listing startup Zango has denied claims by listing giant Domain that its ads misleadingly represented that it will have listings before any of its rivals, saying the ads amounted to “puffery” but admitting that it self-reported the matter to the ACCC.
Otsuka, Bristol-Myers can withdraw admissions in Abilify damages case
A judge has granted a request by Otsuka and Bristol-Myers Squibbs to withdraw admissions in proceedings brought by Generic Health seeking damages, after the generic drug maker was temporarily blocked from selling a generic version of antipsychotic Abilify in a patent dispute in which it ultimately triumphed.